The Transformation of the Pharmaceutical Industry Is Putting Pressure on Finland and Europe
Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
Tatu has worked at Medaffcon since August as an intern. He holds a Master’s Degree in Economics and Business Administration and is currently finalizing his Health Economics studies in the University of Eastern Finland.
Before joining Medaffcon Tatu has worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager with diabetes, respiratory and anticoagulation treatment portfolios.
We want to welcome Tatu to our growing team!

Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
Medaffcon’s Sales Lead Tomi "Tomppa" Vahevaara will retire on October 1st 2026. Tomppa leaves behind an exceptionally long career in the pharmaceutical industry spanning 45 years.
Medaffcon’s new Treatment Dynamics service provides insights into patient journeys, treatment progression, medication use and market dynamics through tailored patient-level real-world data analysis.